NanoVibronix stockholders approve 2024 Long-Term Incentive Plan and elect eight directors at annual meeting.

ENvue Medical, Inc.

Stockholders approved 2024 Long-Term Incentive Plan with 635,057 for, 262,753 against, 2,012 abstentions, and 1,146,998 broker non-votes.
Eight directors elected: Aurora Cassirer, Christopher Fashek, Michael Ferguson, Martin Goldstein, Harold Jacob, Thomas Mika, Brian Murphy, Maria Schroeder, each receiving 668,461–685,652 for votes.
Ratification of Zwik CPA as auditor for FY2024 passed with 2,006,926 for, 25,623 against, 14,271 abstentions.
Advisory vote on executive compensation approved: 629,513 for, 265,874 against, 4,435 abstentions, 1,146,998 broker non-votes.
Adjournment proposal approved (1,656,819 for, 376,540 against) but not needed as meeting proceeded.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.